MetfOrmin BenefIts Lower Extremities with Intermittent Claudication (MOBILE IC): randomized clinical trial protocol

Abstract Background Peripheral artery disease (PAD) affects over 230 million people worldwide and is due to systemic atherosclerosis with etiology linked to chronic inflammation, hypertension, and smoking status. PAD is associated with walking impairment and mobility loss as well as a high prevalenc...

Description complète

Détails bibliographiques

Auteurs principaux:	Katherine M. Reitz, Andrew D. Althouse, Daniel E. Forman, Brian S. Zuckerbraun, Yoram Vodovotz, Ruben Zamora, Robert L. Raffai, Daniel E. Hall, Edith Tzeng
Format:	Artigo
Langue:	Inglês
Publié:	BMC 2023-01-01
Collection:	BMC Cardiovascular Disorders
Sujets:	Peripheral artery disease Intermittent claudication Metformin Anti-inflammatory agents Clinical trial protocol Atherosclerosis
Accès en ligne:	https://doi.org/10.1186/s12872-023-03047-8
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!